394 related articles for article (PubMed ID: 7389195)
1. Migration of blood and synovial fluid neutrophils obtained from patients with rheumatoid arthritis.
Kemp AS; Brown S; Brooks PM; Neoh SH
Clin Exp Immunol; 1980 Jan; 39(1):240-6. PubMed ID: 7389195
[TBL] [Abstract][Full Text] [Related]
2. Study of chemotactic activity developed by neutrophils from rheumatoid arthritis patients.
Bostan M; Constantin MC; Nicolau A; Hirt M; Galatiuc C; Matei I; Braşoveanu LI; Iordăchescu D
Roum Arch Microbiol Immunol; 2002; 61(4):243-58. PubMed ID: 15055258
[TBL] [Abstract][Full Text] [Related]
3. The migratory and phagocytic activity of polymorphonuclear leukocytes in rheumatoid arthritis and osteoarthritis patients.
Dolganiuc A; Stavaru C; Anghel M; Baltaru D; Georgescu E; Olinescu A
Roum Arch Microbiol Immunol; 2000; 59(1-2):43-53. PubMed ID: 11845474
[TBL] [Abstract][Full Text] [Related]
4. Phagocytic function of polymorphonuclear leukocytes in rheumatic diseases.
Turner RA; Schumacher R; Myers AR
J Clin Invest; 1973 Jul; 52(7):1632-5. PubMed ID: 4578156
[TBL] [Abstract][Full Text] [Related]
5. Inhibition of neutrophil migration by sera from patients with rheumatoid arthritis.
Kemp AS; Roberts-Thomson P; Neoh SH; Brown S
Clin Exp Immunol; 1979 Jun; 36(3):423-9. PubMed ID: 487644
[TBL] [Abstract][Full Text] [Related]
6. Detection of interleukin 8 biological activity in synovial fluids from patients with rheumatoid arthritis and production of interleukin 8 mRNA by isolated synovial cells.
Brennan FM; Zachariae CO; Chantry D; Larsen CG; Turner M; Maini RN; Matsushima K; Feldmann M
Eur J Immunol; 1990 Sep; 20(9):2141-4. PubMed ID: 2209707
[TBL] [Abstract][Full Text] [Related]
7. Chemotactic behaviour of peripheral and synovial neutrophils during rifamycin SV therapy in rheumatoid arthritis.
Spisani S; Dovigo L; Marangoni C; Traniello S
J Clin Lab Immunol; 1984 Jun; 14(2):111-4. PubMed ID: 6748046
[TBL] [Abstract][Full Text] [Related]
8. Neutrophil functions in rheumatoid arthritis.
Nada R; Datta U; Deodhar SD; Sehgal S
Indian J Pathol Microbiol; 1999 Jul; 42(3):283-9. PubMed ID: 10862285
[TBL] [Abstract][Full Text] [Related]
9. [Inhibition of polymorphonuclear leukocyte chemotaxis by sera and synovial fluids in rheumatoid arthritis].
Ohseto Y; Negishi M; Takahashi T; Mori Y
Ryumachi; 1984 Jun; 24(3):149-58. PubMed ID: 6505878
[No Abstract] [Full Text] [Related]
10. Immune complexes from rheumatoid arthritis synovial fluid induce FcgammaRIIa dependent and rheumatoid factor correlated production of tumour necrosis factor-alpha by peripheral blood mononuclear cells.
Mathsson L; Lampa J; Mullazehi M; Rönnelid J
Arthritis Res Ther; 2006; 8(3):R64. PubMed ID: 16569263
[TBL] [Abstract][Full Text] [Related]
11. Complement C3c and C3d in plasma and synovial fluid in rheumatoid arthritis.
Berkowicz A; Kappelgaard E; Petersen J; Nielsen H; Ingemann-Hansen T; Halkjaer-Kristensen J; Sørensen H
Acta Pathol Microbiol Immunol Scand C; 1983 Dec; 91(6):397-402. PubMed ID: 6608857
[TBL] [Abstract][Full Text] [Related]
12. [Leukocyte migration inhibitory factor of synovial fluid lymphocytes in rheumatoid arthritis].
Ogino M
Nihon Seikeigeka Gakkai Zasshi; 1984 Jan; 58(1):59-67. PubMed ID: 6379072
[TBL] [Abstract][Full Text] [Related]
13. Synovial fluid levels of anti-cyclic citrullinated peptide antibodies and IgA rheumatoid factor in rheumatoid arthritis, psoriatic arthritis, and osteoarthritis.
Caspi D; Anouk M; Golan I; Paran D; Kaufman I; Wigler I; Levartovsky D; Litinsky I; Elkayam O
Arthritis Rheum; 2006 Feb; 55(1):53-6. PubMed ID: 16463412
[TBL] [Abstract][Full Text] [Related]
14. Defective serum chemotactic capacity in rheumatoid arthritis.
Attia WM; Ali MK; Abu-Ghazalah LM; Shams AH; Clark HW; Brown TM; Bellanti JA
Ann Allergy; 1983 Apr; 50(4):266-70. PubMed ID: 6838025
[TBL] [Abstract][Full Text] [Related]
15. Complement C4-derived monocyte-directed chemotaxis-inhibitory factor. A molecular mechanism to cause polymorphonuclear leukocyte-predominant infiltration in rheumatoid arthritis synovial cavities.
Matsubara S; Yamamoto T; Tsuruta T; Takagi K; Kambara T
Am J Pathol; 1991 May; 138(5):1279-91. PubMed ID: 2024711
[TBL] [Abstract][Full Text] [Related]
16. Studies into the occurrence of soluble antigen-antibody complexes in disease. VII. Clinical-laboratory correlations of immunoglobulin complexes in rheumatoid synovial fluid.
Russell ML; Gordon DA; BRoder I
J Rheumatol; 1974 Jun; 1(2):153-8. PubMed ID: 4477197
[No Abstract] [Full Text] [Related]
17. Anti-Fc gamma receptor III autoantibody is associated with soluble receptor in rheumatoid arthritis serum and synovial fluid.
Lamour A; Baron D; Soubrane C; Cartron J; Khayat D; Adler Y; Le Goff P; Youinou P
J Autoimmun; 1995 Apr; 8(2):249-65. PubMed ID: 7612151
[TBL] [Abstract][Full Text] [Related]
18. RANTES and chemotactic activity in synovial fluids from patients with rheumatoid arthritis and osteoarthritis.
Stanczyk J; Kowalski ML; Grzegorczyk J; Szkudlinska B; Jarzebska M; Marciniak M; Synder M
Mediators Inflamm; 2005 Dec; 2005(6):343-8. PubMed ID: 16489254
[TBL] [Abstract][Full Text] [Related]
19. Immunomodulation of neutrophil chemotaxis in rheumatoid arthritis using levamisole and methisoprinol.
Mazzone A; Baigura R; Rossini S; Ricevuti G
Clin Ther; 1986; 8(2):232-7. PubMed ID: 2421905
[TBL] [Abstract][Full Text] [Related]
20. Cytomorphological, ultrastructural and immunological particularities of the synovial fluid in seronegative rheumatoid arthritis.
Ciobanu A; Ciobanu IR; Stoicescu M; Stroescu I; Ioniţă A; Caralicea M; Curuţ O
Rom J Morphol Embryol; 1992; 38(3-4):129-41. PubMed ID: 1342200
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
